Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection.

bacterial cellulose doxorubicin intraperitoneal chemotherapy nanofibrillated bacterial cellulose peritoneally disseminated gastric cancer

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
28 Jun 2021
Historique:
received: 13 06 2021
revised: 23 06 2021
accepted: 25 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

Natural materials such as bacterial cellulose are gaining interest for their use as drug-delivery vehicles. Herein, the utility of nanofibrillated bacterial cellulose (NFBC), which is produced by culturing a cellulose-producing bacterium (

Identifiants

pubmed: 34203462
pii: nano11071697
doi: 10.3390/nano11071697
pmc: PMC8307241
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 19H02549
Organisme : Japan Society for the Promotion of Science
ID : 19H02549

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Carbohydr Polym. 2014 Jan;99:98-100
pubmed: 24274484
Carbohydr Polym. 2018 Oct 15;198:131-141
pubmed: 30092983
Int J Pharm. 2017 Nov 25;533(1):285-297
pubmed: 28951349
Clin Cancer Res. 2012 May 1;18(9):2668-78
pubmed: 22421191
Nanomaterials (Basel). 2020 Aug 29;10(9):
pubmed: 32872399
Biomacromolecules. 2006 Jun;7(6):1687-91
pubmed: 16768384
Microb Biotechnol. 2019 Jul;12(4):586-610
pubmed: 30838788
J Biol Chem. 1986 Mar 5;261(7):3060-7
pubmed: 3456345
Semin Oncol. 1986 Sep;13(3 Suppl 3):54-62
pubmed: 3020702
Ann Intern Med. 1979 Nov;91(5):710-7
pubmed: 496103
Microbiol Rev. 1991 Mar;55(1):35-58
pubmed: 2030672
Polymers (Basel). 2017 Apr 12;9(4):
pubmed: 30970818
Int J Nanomedicine. 2017 Mar 14;12:2021-2031
pubmed: 28352172
Gastric Cancer. 2017 Mar;20(Suppl 1):122-127
pubmed: 27766496
ACS Appl Mater Interfaces. 2013 May;5(9):3884-93
pubmed: 23551195
Annu Rev Cell Dev Biol. 2006;22:53-78
pubmed: 16824006
Semin Oncol. 2001 Aug;28(4 Suppl 12):15-23
pubmed: 11552226
Ann Bot. 2005 Jul;96(1):9-21
pubmed: 15894551
Appl Microbiol Biotechnol. 2011 Sep;91(5):1277-86
pubmed: 21744133
J Cell Biol. 1982 Jul;94(1):64-9
pubmed: 6889605
Biomacromolecules. 2017 Oct 9;18(10):3432-3438
pubmed: 28876907
J Urol. 1995 Mar;153(3 Pt 2):894-900
pubmed: 7853569
Int J Biol Macromol. 2021 Mar 31;174:494-501
pubmed: 33545180
Gastric Cancer. 2017 Mar;20(Suppl 1):111-121
pubmed: 27803990
Bioresour Technol. 2014 Jan;151:113-9
pubmed: 24212131
Drug Deliv. 2020 Dec;27(1):460-468
pubmed: 32166987
Appl Microbiol Biotechnol. 2016 Mar;100(5):2063-72
pubmed: 26743657
Biotechnol Rep (Amst). 2019 Feb 15;21:e00316
pubmed: 30847286
Sci Rep. 2016 Jun 23;6:28596
pubmed: 27334142
Plant Cell Physiol. 2002 Dec;43(12):1407-20
pubmed: 12514238

Auteurs

Hidenori Ando (H)

Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Takashi Mochizuki (T)

Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Amr S Abu Lila (ASA)

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Department of Pharmaceutics, College of Pharmacy, Hail University, Hail 81442, Saudi Arabia.

Shunsuke Akagi (S)

Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Kenji Tajima (K)

Faculty of Engineering, Hokkaido University, Hokkaido 060-8628, Japan.

Kenji Fujita (K)

Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Taro Shimizu (T)

Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Yu Ishima (Y)

Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Tokuo Matsushima (T)

Kusano Sakko Inc., Hokkaido 067-0063, Japan.

Takatomo Kusano (T)

Kusano Sakko Inc., Hokkaido 067-0063, Japan.

Tatsuhiro Ishida (T)

Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima 770-8505, Japan.

Classifications MeSH